TrialCancer science2018

Phase II study of ceritinib in alectinib-pretreated patients with anaplastic lymphoma kinase-rearranged metastatic non-small-cell lung cancer in Japan: ASCEND-9.

Toyoaki Hida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.